Brewing counteracts low carb knock for Novozymes

- Last updated on GMT

Related tags: Low-carbohydrate diet, Carbohydrate, Novozymes

Slight growth for Danish enzymes giant Novozymes in the first half
of the year with Europe providing steady returns but US market
knocked by the popular low carbohydrate diet that has hit the
baking industry.

On the back of total sales for the business - enzymes and microorganisms - exceeding €400m (DKK2,976m) for the first six months, the food enzyme sector of the business brought in €93m (DKK695m) worth of sales, translating as a one per cent rise on the year before and roughly one quarter of the firm's overall enzyme business that includes technical and feed enzymes.

But a growing trend in the US is seeing consumers avidly following the low-carb Atkins diet that eschews carbohydrates in favour of proteins - a phenomenon that has started to knock ingredients firms with a stake in the North American market.

"Sales to the baking industry continue to be negatively affected by lower bread consumption in the USA,"​ said Novozymes in a statement yesterday.

By comparison, sales to the brewing industry were actually favourably affected by the low-carb diet that has an estimated 30 million followers in the US. According to the Bagsværd-based firm, enzymes sales to the brewing industry rose, 'partly due to an increase in the demand for low-carbohydrate beer produced using enzymes.'

Hinting at a steady outlook for the region in the next quarter, Novozymes said: "Taking the second quarter in isolation, sales to the baking industry have stabilised and sales to the wine and juice industry have increased, thanks to sales starting earlier this year than in the equivalent period of 2003."

A spokesperson for the firm told FoodNavigator.com that the low-carb trend has yet to affect food enzyme sales in Europe.

The firm reported a 2 per cent rise on total business sales for Europe, Middle East and Africa to DKK1,293m (€173m) for the first half, up from DKK1263m for the same period in 2003.

Looking forward to the rest of the year, Novozymes predicted that growth in net profit remains at 7 per cent, with growth in operating profit 'still expected' to reach 9 to 10 per cent. Net profit for the first half of 2004 rose by 5 per cent to DKK378m, up from 361m from the previous year.

Related news

Show more

Related products

show more

GemPro Wheat Proteins

GemPro Wheat Proteins

Manildra Group USA | 13-May-2020 | Product Brochure

Wheat proteins provide more than just strength. If you are looking to boost protein, improve rheology, or enhance texture, it all begins with wheat proteins....

The rising challenge of clean label baking

The rising challenge of clean label baking

DuPont Nutrition & Biosciences | Recorded the 12-Mar-2020 | Webinar

Addressing consumer trends versus product quality and process efficiency
Clean label bread represents a growing opportunity within Europe. 'Natural'...

Developing with Plant Protein for Success

Developing with Plant Protein for Success

Almond Board of California | Recorded the 19-Feb-2020 | Webinar

Join the Almond Board of California (ABC) to discover the positive attributes almonds bring to plant-based products and learn more about protein-rich ingredient...

Related suppliers

Follow us

Products

View more

Webinars